Approval · Notice of Compliance 12243 · 2011
AVA-INDAPAMIDE: Notice of Compliance 12243
Issued April 4, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12243
- Date
- April 4, 2011
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Diuretic / Antihypertensive agent
- Canadian reference product
- LOZIDE (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-INDAPAMIDE | 02364611 | — |
| AVA-INDAPAMIDE | 02364638 | — |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB
- INDAPAMIDE 2.5 MG per TAB